The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Eisai
Efficacy and safety of lenvatinib for the treatment of patients with 131I-refractory differentiated thyroid cancer with and without prior VEGF-targeted therapy.
 
Kate Newbold
Consulting or Advisory Role - AstraZeneca; Eisai; Genzyme
Research Funding - AstraZeneca (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Rossella Elisei
Honoraria - Bayer; Exelixis; Genzyme
Consulting or Advisory Role - Novartis
Speakers' Bureau - Bayer; Exelixis; Genzyme
Travel, Accommodations, Expenses - Genzyme
 
Matthew Hiram Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Monika K. Krzyzanowska
Honoraria - Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst)
Other Relationship - Bayer/Onyx
 
Manisha H. Shah
Consulting or Advisory Role - Eisai
Research Funding - Eisai; Exelixis
 
Ana O. Hoff
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - Eisai
Travel, Accommodations, Expenses - Eisai
 
Bruce Robinson
Honoraria - AstraZeneca; Bayer; Eisai
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai
 
Corina Dutcus
Employment - Eisai
 
James Song
No Relationships to Disclose
 
Mouhammed Amir Habra
Honoraria - Eisai
Research Funding - Eisai
Travel, Accommodations, Expenses - Eisai